Tomomi M. Yamamoto

机构：University of Colorado Anschutz Medical Campus · ORCID：0000-0002-6666-5406

发表论文 423 篇 · 总被引 2906 次 · h-index 31

代表论文

Inhibiting CXCR2 remodels the tumor microenvironment and blunts tumor progression and dissemination of high-grade serous carcinoma (2026 · Cancer Research Communications)
Figure S2 from Chromobox 2 Inhibition: A Novel Activity of Alisertib, an Aurora A Kinase Inhibitor (2026)
Figure S3 from Chromobox 2 Inhibition: A Novel Activity of Alisertib, an Aurora A Kinase Inhibitor (2026)
Figure S6 from Chromobox 2 Inhibition: A Novel Activity of Alisertib, an Aurora A Kinase Inhibitor (2026)
Data from Chromobox 2 Inhibition: A Novel Activity of Alisertib, an Aurora A Kinase Inhibitor (2026)
Figure S4 from Chromobox 2 Inhibition: A Novel Activity of Alisertib, an Aurora A Kinase Inhibitor (2026)